Abeona Therapeutics (NASDAQ:ABEO) Upgraded to Hold at StockNews.com

StockNews.com upgraded shares of Abeona Therapeutics (NASDAQ:ABEO – Free Report) from a sell rating to a hold rating in a research note released on Friday. ABEO has been the subject of several other reports. Cantor Fitzgerald reiterated an “overweight” rating and issued a $18.00 target price on shares of Abeona Therapeutics in a research note […]

Leave a Reply

Your email address will not be published.

Previous post T. Rowe Price Group (NASDAQ:TROW) Rating Increased to Buy at StockNews.com
Next post Dayforce (NYSE:DAY) Price Target Raised to $90.00